Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 17 Jul 2026 for Catalyst Pharmaceuticals, INC., €6.7M. Read the official filing
Filing timeline
BuySaleBrian Elsbernd
Insider track record
Disclosed buys
0
Disclosed sells
3
Signal history
Brian Elsbernd: trading record in brief
Brian Elsbernd is a declared insider of Catalyst Pharmaceuticals, Inc. (senior executive), with filings sourced from SEC (Form 4). The record holds 22 filings, for trades running from 3 December 2021 to 15 July 2026.
Every open-market trade on record is a sale: 3 sales worth €1.4M. Other entries cover 2 share grants and 16 option exercises.
Most recently, on 17 July 2026, the filings show a transaction worth €6.7M in Catalyst Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Brian Elsbernd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
242,501 shares@ US$31.500.20% mcap77.7% of flowCommon Stock, par value $0.001 per shareSEC:0001161697-26-000176:0
6,667 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000491:0
2,623 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000491:1
7,067 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000445:0
5,161 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000416:0
40,000 shares@ US$22.709.1% of flowCommon Stock, par value $0.001 per shareSEC:0001161697-25-000374:0
112,475 shares@ US$2.242.5% of flowCommon Stock, par value $0.001 per shareSEC:0001161697-25-000320:0
20,000 shares@ US$2.240.4% of flowCommon Stock, par value $0.001 per shareSEC:0001161697-25-000318:0
9,270 shares@ US$2.240.2% of flowCommon Stock, par value $0.001 per shareSEC:0001161697-25-000085:0
9,667 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000067:0
6,667 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-24-000539:0
1,941 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-24-000539:1
7,067 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-24-000501:0
50,244 shares@ US$4.012.2% of flowCommon Stock, par value $0.001 per shareSEC:0001161697-24-000490:0
25,000 shares@ US$16.444.4% of flowCommon stock, par value $0.001 per shareSEC:0001161697-24-000164:0
9,667 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-24-000100:0
6,666 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-23-000645:0
50,000 shares@ US$1.130.6% of flowCommon Stock, par value $0.001 per shareSEC:0001161697-23-000173:0
9,666 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-23-000127:0
14,667 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-22-000572:0
14,666 shares@ US$16.2352.7% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000549:0
14,667 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-21-000561:0
22 of 22 declarations
